UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPD

Pulmonary pharmacology & therapeutics, 2010-08, Vol.23 (4), p.345-354

2010

Volltextzugriff (PDF)

In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor

The Journal of pharmacology and experimental therapeutics, 2001-04, Vol.297 (1), p.280

2001

Volltextzugriff (PDF)

605 Nintedanib safely reduces radiation-induced lung damage in a mouse model of partial lung irradiation

European journal of cancer (1990), 2015-09, Vol.51, p.S118-S118

2015

Volltextzugriff (PDF)

Spleen tyrosine kinase inhibition blocks airway constriction and protects from Th2‐induced airway inflammation and remodeling

Allergy (Copenhagen), 2017-07, Vol.72 (7), p.1061-1072

2017

Volltextzugriff (PDF)

The Effect of Nintedanib on T-Cell Activation, Subsets and Functions

Drug design, development and therapy, 2021-01, Vol.15, p.997-1011

2021

Volltextzugriff (PDF)

Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib

Drug design, development and therapy, 2015-01, Vol.9 (Issue 1), p.6407-6419

2015

Volltextzugriff (PDF)

Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors

Pulmonary pharmacology & therapeutics, 2006-01, Vol.19 (5), p.343-352

2006

Volltextzugriff (PDF)

The effect of nintedanib versus mycophenolate mofetil in the Fra2 mouse model of systemic sclerosis-associated interstitial lung disease

Clinical and Experimental Rheumatology, 2021-07, Vol.39 Suppl 131 (4), p.134-141

2021

Volltextzugriff (PDF)

B32 REGULATION OF INFLAMMATION AND LUNG INJURY I: The Combination Of Tiotropium And Olodaterol Attenuates Pulmonary Inflammation In Mice

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

C64 HAVING A BLAST WITH FIBROBLASTS: The Effect Of Nintedanib Compared To Pirfenidone On Serum-Stimulated Proliferation Of Human Primary Lung Fibroblasts At Clinically Relevant Concentrations

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

A74 REGULATORY MECHANISMS OF THE MOLECULAR PATHWAYS IN FIBROSIS: Nintedanib Inhibits Pro-Fibrotic Mediators With Relevance In Connective Tissue Disease-Associated Interstitial Lung Diseases

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

Anti-entzündliche Wirkung von Tiotropium in einem Mausmodell für chronisch obstruktive Atemwegserkrankungen (COPD)

Pneumologie (Stuttgart, Germany), 2010, Vol.64 (S 03)

2010

Volltextzugriff (PDF)

Nintedanib hemmt die Proliferation, die Migration und die Transformation von Lungenfibroblasten aus Patienten mit idiopathischer Lungenfibrose

Pneumologie (Stuttgart, Germany), 2015, Vol.69 (S 01)

2015

Volltextzugriff (PDF)

Roflumilast Fully Prevents Emphysema in Mice Chronically Exposed to Cigarette Smoke

American journal of respiratory and critical care medicine, 2005-10, Vol.172 (7), p.848-853

2005

Volltextzugriff (PDF)

P.169 Nintedanib improves muscle function and reduces fibrosis in a murine model of alpha-sarcoglycanopthy

Neuromuscular disorders : NMD, 2022-10, Vol.32, p.S116

2022

Volltextzugriff (PDF)

A73 LUNG FIBROSIS: NEW DIRECTIONS TO INFORM THE FUTURE: The Effect Of Nintedanib On Platelet Derived Growth Factor-Stimulated Contraction Of Human Primary Lung Fibroblasts

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

C34 INSIGHTS INTO COPD PATHOGENESIS FROM PRE-CLINICAL STUDIES: Olodaterol Inhibits Cell Influx In Models Of Cigarette Smoke- And Lipopolysaccharide-Induced Lung Inflammation

American journal of respiratory and critical care medicine, 2014-01, Vol.189, p.1

2014

Volltextzugriff (PDF)

A74 REGULATORY MECHANISMS OF THE MOLECULAR PATHWAYS IN FIBROSIS: Modulation Of Normal And Idiopathic Pulmonary Fibrosis Lung Fibroblast Motility And Invasion By Nintedanib

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

A74 REGULATORY MECHANISMS OF THE MOLECULAR PATHWAYS IN FIBROSIS: Nintedanib Effectively Inhibits Carbon Nanotube-Induced Fibrotic Responses In Human Alveolar Epithelial Cells, Fibroblasts And Pulmonary Microvascular Endothelial Cells

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

Antifibrotics effects of nintedanib on lung fibroblasts derived from patients with progressive fibrosing intertitial lung diseases

Revue des maladies respiratoires, 2022-02, Vol.39 (2), p.128-129

2022

Volltextzugriff (PDF)

Arsenic trioxide inhibits the functions of lung fibroblasts derived from patients with idiopathic pulmonary fibrosis

Revue des maladies respiratoires, 2022-02, Vol.39 (2), p.129-129

2022

Volltextzugriff (PDF)

B62 THE BIOLOGY OF SCARRING. WHERE ARE WE NOW: Nintedanib Reduces Pulmonary Fibrosis In A Model Of Rheumatoid Arthritis Associated Interstitial Lung Disease

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

A52 PRECLINICAL TRIALS IN PULMONARY HYPERTENSION MODELS: NOVEL TARGETS AND DELIVERY: Vasorelaxant Properties Of Nintedanib In The Murine Pulmonary Circulation

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

C42 SEARCHIN' FOR A CURE: NEW ILD TREATMENTS: Effects Of Nintedanib On The Microvascular Architecture In A Bleomycin-Induced Pulmonray Fibrosis Model

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

A72 MECHANISMS DRIVING FIBROSIS: Nintedanib Attenuates The Polarization Of Profibrotic Macrophages Through The Inhibition Of Tyrosine Phosphorylation On Csf1 Receptor

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

1 – 25 von 147

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(128)
Mit Volltextzugriff
(101)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPD

In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor

605 Nintedanib safely reduces radiation-induced lung damage in a mouse model of partial lung irradiation

Spleen tyrosine kinase inhibition blocks airway constriction and protects from Th2‐induced airway inflammation and remodeling

The Effect of Nintedanib on T-Cell Activation, Subsets and Functions

Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib

Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors

The effect of nintedanib versus mycophenolate mofetil in the Fra2 mouse model of systemic sclerosis-associated interstitial lung disease

B32 REGULATION OF INFLAMMATION AND LUNG INJURY I: The Combination Of Tiotropium And Olodaterol Attenuates Pulmonary Inflammation In Mice

C64 HAVING A BLAST WITH FIBROBLASTS: The Effect Of Nintedanib Compared To Pirfenidone On Serum-Stimulated Proliferation Of Human Primary Lung Fibroblasts At Clinically Relevant Concentrations

A74 REGULATORY MECHANISMS OF THE MOLECULAR PATHWAYS IN FIBROSIS: Nintedanib Inhibits Pro-Fibrotic Mediators With Relevance In Connective Tissue Disease-Associated Interstitial Lung Diseases

Anti-entzündliche Wirkung von Tiotropium in einem Mausmodell für chronisch obstruktive Atemwegserkrankungen (COPD)

Nintedanib hemmt die Proliferation, die Migration und die Transformation von Lungenfibroblasten aus Patienten mit idiopathischer Lungenfibrose

Roflumilast Fully Prevents Emphysema in Mice Chronically Exposed to Cigarette Smoke

P.169 Nintedanib improves muscle function and reduces fibrosis in a murine model of alpha-sarcoglycanopthy

A73 LUNG FIBROSIS: NEW DIRECTIONS TO INFORM THE FUTURE: The Effect Of Nintedanib On Platelet Derived Growth Factor-Stimulated Contraction Of Human Primary Lung Fibroblasts

C34 INSIGHTS INTO COPD PATHOGENESIS FROM PRE-CLINICAL STUDIES: Olodaterol Inhibits Cell Influx In Models Of Cigarette Smoke- And Lipopolysaccharide-Induced Lung Inflammation

A74 REGULATORY MECHANISMS OF THE MOLECULAR PATHWAYS IN FIBROSIS: Modulation Of Normal And Idiopathic Pulmonary Fibrosis Lung Fibroblast Motility And Invasion By Nintedanib

A74 REGULATORY MECHANISMS OF THE MOLECULAR PATHWAYS IN FIBROSIS: Nintedanib Effectively Inhibits Carbon Nanotube-Induced Fibrotic Responses In Human Alveolar Epithelial Cells, Fibroblasts And Pulmonary Microvascular Endothelial Cells

Antifibrotics effects of nintedanib on lung fibroblasts derived from patients with progressive fibrosing intertitial lung diseases

Arsenic trioxide inhibits the functions of lung fibroblasts derived from patients with idiopathic pulmonary fibrosis

B62 THE BIOLOGY OF SCARRING. WHERE ARE WE NOW: Nintedanib Reduces Pulmonary Fibrosis In A Model Of Rheumatoid Arthritis Associated Interstitial Lung Disease

A52 PRECLINICAL TRIALS IN PULMONARY HYPERTENSION MODELS: NOVEL TARGETS AND DELIVERY: Vasorelaxant Properties Of Nintedanib In The Murine Pulmonary Circulation

C42 SEARCHIN' FOR A CURE: NEW ILD TREATMENTS: Effects Of Nintedanib On The Microvascular Architecture In A Bleomycin-Induced Pulmonray Fibrosis Model

A72 MECHANISMS DRIVING FIBROSIS: Nintedanib Attenuates The Polarization Of Profibrotic Macrophages Through The Inhibition Of Tyrosine Phosphorylation On Csf1 Receptor

Suchergebnisse filtern